Providing a correlation between polymorphisms and breast cancer. Diagnosis of breast cancer, to provide a method for prognosis, and treatment. Diagnosis of breast cancer, to provide a system and a kit for the prognosis, and treatment. Method for identifying a breast cancer modulators are also ...
(2010) PKCalpha expression is a marker for breast cancer aggressiveness . Mol Cancer 9 : 76. 10.1186/1476-4598-9-76 PubMed: 20398285Lonne GK, Cornmark L, Zahirovic IO, Landberg G, Jirstrom K, Larsson C. PKCalpha expression is a marker for breast cancer aggressiveness. Mol. Cancer. ...
While the risk associated with this genetic marker is much lower than that of BRCA genetic mutations for example, this discovery will increase the understanding of the genetic variants that contribute to breast cancer. Researchers used samples largely from MSKCC, but also from other sites in the U...
"These little gas-filled microbubbles stick to humanbreast tissuefor days and can be seen with ultrasound," said William Trogler, professor chemistry. "If doctors placed them in early stage breast cancer, which is difficult to see during surgery, they could help surgeons remove all of it in ...
Placental Isoferritin – A Marker for Early Breast Cancer? - First Results of a Multicenter Study Berkeley Electronic Press Selected Works M Hellan,L Auerbach,HR Rosen,... - Senology: Proceedings of the 7th International Congress on Senology (Breast Diseases), Island of Rhodes, Greece, 3-7 ...
This marker makes drug production possible for metastatic BLBC in the near future, the study noted. BLBC, referred to as triple-negative breast cancer, is unresponsive to many traditional treatments, is much more likely to metastasize, and has a poor prognosis once diagnosed. ...
The present invention relates to the diagnosis of breast cancer. It discloses the use of ubiquitin-conjugating enzyme E2N (UBC13) in the diagnosis of breast cancer. It relates to a method for diagnosis of breast cancer from a liquid sample, derived from an individual by measuring UBC13 in ...
4.Dash N, Chafin SH, Johnson RR, Contractor FM. Usefulness of tissue marker clips in patients undergoing neoadjuvant chemotherapy for breast cancer. AJR Am J Roentgenol. 1999;173:911–917. [PubMed] [Google Scholar] 5.Thomassin-Naggara I, Lalonde L, David J, ...
free PSA as the predominant form was found to be highly specific for breast cancer when compared to benign and normal tissues. 3 In India, Dash et al.,(2011) in their study in Indian population observed similar results using total and free PSA in patients of breast tumors 5 augmenting ?
Mammaglobin, a breast-specific gene, and its utility as a marker for breast cancer. Fleming TP,Watson MA.Mammaglobin, a breast-specific gene, and its utility as a marker for breast cancer. Annals of the New York Academy of Sciences ... TP Fleming,MA Watson - 《Annals of the New York ...